| Year |
Citation |
Score |
| 2021 |
Chen JA, Hou Y, Roskin KM, Arber DA, Bangs CD, Baughn LB, Cherry AM, Ewalt MD, Fire AZ, Fresard L, Kearney HM, Montgomery SB, Ohgami RS, Pearce KE, Pitel BA, ... Merker JD, et al. Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance. Blood Advances. 5: 3492-3496. PMID 34505882 DOI: 10.1182/bloodadvances.2020004174 |
0.6 |
|
| 2020 |
Keegan A, Bridge JA, Lindeman NI, Long TA, Merker JD, Moncur JT, Montgomery ND, Nagarajan R, Rothberg PG, Routbort MJ, Vasalos P, Xian R, Kim AS. Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies. Archives of Pathology & Laboratory Medicine. PMID 31986076 DOI: 10.5858/Arpa.2019-0352-Cp |
0.359 |
|
| 2020 |
Lockwood CM, Souers RJ, Vasalos P, Kalicanin T, Devereaux K, Graham RP, Hameed M, Routbort M, Tsai JM, Merker JD, Lindeman NI, Moncur JT. Performance of cell-free tumor DNA testing for 101 clinical laboratories on College of American Pathologists proficiency tests. Journal of Clinical Oncology. 38: e13681-e13681. DOI: 10.1200/Jco.2020.38.15_Suppl.E13681 |
0.397 |
|
| 2019 |
Fernandez-Pol S, Costa HA, Steiner DF, Ma L, Merker JD, Kim YH, Arber DA, Kim J. High-throughput Sequencing of Subcutaneous Panniculitis-like T-Cell Lymphoma Reveals Candidate Pathogenic Mutations. Applied Immunohistochemistry & Molecular Morphology : Aimm. 27: 740-748. PMID 31702703 DOI: 10.1097/Pai.0000000000000683 |
0.378 |
|
| 2019 |
Frésard L, Smail C, Ferraro NM, Teran NA, Li X, Smith KS, Bonner D, Kernohan KD, Marwaha S, Zappala Z, Balliu B, Davis JR, Liu B, Prybol CJ, Kohler JN, ... ... Merker JD, et al. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nature Medicine. PMID 31160820 DOI: 10.1038/S41591-019-0457-8 |
0.329 |
|
| 2019 |
Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Archives of Pathology & Laboratory Medicine. PMID 30969158 DOI: 10.5858/Arpa.2018-0396-Cp |
0.33 |
|
| 2019 |
Surrey LF, Oakley FD, Merker JD, Long TA, Vasalos P, Moncur JT, Kim AS. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on BRAF, EGFR, and KRAS Proficiency Testing Samples. Archives of Pathology & Laboratory Medicine. PMID 30865489 DOI: 10.5858/Arpa.2018-0394-Cp |
0.335 |
|
| 2018 |
Santani A, Simen BB, Briggs M, Lebo M, Merker JD, Nikiforova M, Vasalos P, Voelkerding K, Pfeifer J, Funke B. Designing and Implementing NGS Tests for Inherited Disorders - a Practical Framework with Step-by-Step Guidance for Clinical Laboratories. The Journal of Molecular Diagnostics : Jmd. PMID 30605766 DOI: 10.1016/J.Jmoldx.2018.11.004 |
0.321 |
|
| 2018 |
Merker JD, Devereaux K, Iafrate AJ, Kamel-Reid S, Kim AS, Moncur JT, Montgomery SB, Nagarajan R, Portier BP, Routbort MJ, Smail C, Surrey LF, Vasalos P, Lazar AJ, Lindeman NI. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. Archives of Pathology & Laboratory Medicine. PMID 30376374 DOI: 10.5858/Arpa.2018-0336-Cp |
0.356 |
|
| 2018 |
Muñoz-González JI, Jara-Acevedo M, Alvarez-Twose I, Merker JD, Teodosio C, Hou Y, Henriques A, Roskin KM, Sanchez-Muñoz L, Tsai AG, Caldas C, Matito A, Sánchez-Gallego JI, Mayado A, Dasilva-Freire N, et al. Impact of somatic and germline mutations on the outcome of systemic mastocytosis. Blood Advances. 2: 2814-2828. PMID 30373888 DOI: 10.1182/Bloodadvances.2018020628 |
0.397 |
|
| 2018 |
Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017768671. PMID 29504847 DOI: 10.1200/Jco.2017.76.8671 |
0.322 |
|
| 2018 |
Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Archives of Pathology & Laboratory Medicine. PMID 29504834 DOI: 10.5858/Arpa.2018-0901-Sa |
0.315 |
|
| 2017 |
Nagarajan R, Bartley AN, Bridge JA, Jennings LJ, Kamel-Reid S, Kim A, Lazar AJ, Lindeman NI, Moncur J, Rai AJ, Routbort MJ, Vasalos P, Merker JD. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices. Archives of Pathology & Laboratory Medicine. PMID 29028368 DOI: 10.5858/Arpa.2016-0542-Cp |
0.324 |
|
| 2017 |
Chung A, Hou Y, Ohgami RS, Von Gehr A, Fisk DG, Roskin KM, Li X, Gojenola L, Bangs CD, Arber DA, Fire AZ, Cherry AM, Zehnder JL, Gotlib J, Merker JD. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia. Cancer Genetics. 216: 10-15. PMID 29025582 DOI: 10.1016/J.Cancergen.2017.05.001 |
0.33 |
|
| 2017 |
Li X, Kim Y, Tsang EK, Davis JR, Damani FN, Chiang C, Hess GT, Zappala Z, Strober BJ, Scott AJ, Li A, Ganna A, Bassik MC, Merker JD, et al. The impact of rare variation on gene expression across tissues. Nature. 550: 239-243. PMID 29022581 DOI: 10.1038/Nature24267 |
0.317 |
|
| 2017 |
Shoura MJ, Gabdank I, Hansen L, Merker J, Gotlib J, Levene SD, Fire AZ. Intricate and Cell-type-specific Populations of Endogenous Circular DNA (eccDNA) in Caenorhabditis elegans and Homo sapiens. G3 (Bethesda, Md.). PMID 28801508 DOI: 10.1534/G3.117.300141 |
0.353 |
|
| 2017 |
Merker JD, Wenger AM, Sneddon T, Grove M, Zappala Z, Fresard L, Waggott D, Utiramerur S, Hou Y, Smith KS, Montgomery SB, Wheeler M, Buchan JG, Lambert CC, Eng KS, et al. Long-read genome sequencing identifies causal structural variation in a Mendelian disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 28640241 DOI: 10.1038/Gim.2017.86 |
0.385 |
|
| 2016 |
Duncavage EJ, Abel HJ, Merker JD, Bodner JB, Zhao Q, Voelkerding KV, Pfeifer JD. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing. Archives of Pathology & Laboratory Medicine. PMID 27388684 DOI: 10.5858/Arpa.2016-0194-Cp |
0.365 |
|
| 2016 |
Ozawa MG, Bhaduri A, Chisholm KM, Baker SA, Ma L, Zehnder JL, Luna-Fineman S, Link MP, Merker JD, Arber DA, Ohgami RS. A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27338637 DOI: 10.1038/Modpathol.2016.102 |
0.331 |
|
| 2015 |
Ohgami RS, Ma L, Merker JD, Gotlib JR, Schrijver I, Zehnder JL, Arber DA. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 28: 706-14. PMID 25412851 DOI: 10.1038/Modpathol.2014.160 |
0.354 |
|
| 2015 |
Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, et al. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. Archives of Pathology & Laboratory Medicine. 139: 481-93. PMID 25152313 DOI: 10.5858/Arpa.2014-0250-Cp |
0.35 |
|
| 2014 |
Boyd SD, Galli SJ, Schrijver I, Zehnder JL, Ashley EA, Merker JD. A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical Care. Genes. 5: 748-66. PMID 25257203 DOI: 10.3390/Genes5030748 |
0.331 |
|
| 2014 |
Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, Caleshu C, Kingham K, Klein TE, et al. Clinical interpretation and implications of whole-genome sequencing. Jama. 311: 1035-45. PMID 24618965 DOI: 10.1001/Jama.2014.1717 |
0.346 |
|
| 2013 |
Merker JD, Roskin KM, Ng D, Pan C, Fisk DG, King JJ, Hoh R, Stadler M, Okumoto LM, Abidi P, Hewitt R, Jones CD, Gojenola L, Clark MJ, Zhang B, et al. Comprehensive whole-genome sequencing of an early-stage primary myelofibrosis patient defines low mutational burden and non-recurrent candidate genes. Haematologica. 98: 1689-96. PMID 23872309 DOI: 10.3324/Haematol.2013.092379 |
0.424 |
|
| 2013 |
Merker JD, O'Grady N, Gojenola L, Dao M, Lenta R, Yeakley JM, Schrijver I. Feasibility of using microbeads with holographic barcodes to track DNA specimens in the clinical molecular laboratory. Peerj. 1: e91. PMID 23862106 DOI: 10.7717/Peerj.91 |
0.345 |
|
| 2012 |
Merker JD, Valouev A, Gotlib J. Next-generation sequencing in hematologic malignancies: what will be the dividends? Therapeutic Advances in Hematology. 3: 333-9. PMID 23606936 DOI: 10.1177/2040620712458948 |
0.345 |
|
| 2012 |
Merker JD, Roskin K, Ng D, Pan C, Fisk DG, Jones CD, Gojenola L, Clark MJ, Zhang B, Cherry M, Snyder M, Boyd SD, Zehnder JL, Fire AZ, Gotlib J. Whole Genome Sequence Analysis of Primary Myelofibrosis. Blood. 120: 2863-2863. DOI: 10.1182/Blood.V120.21.2863.2863 |
0.411 |
|
| 2010 |
Boyd SD, Gaëta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, et al. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. Journal of Immunology (Baltimore, Md. : 1950). 184: 6986-92. PMID 20495067 DOI: 10.4049/Jimmunol.1000445 |
0.334 |
|
| 2010 |
Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs KD, Merker JD, Zehnder JL, Nolan GP, Gotlib J. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood. 116: 988-92. PMID 20404132 DOI: 10.1182/Blood-2010-02-270108 |
0.332 |
|
| 2010 |
Merker JD, Jones CD, Oh ST, Schrijver I, Gotlib J, Zehnder JL. Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory. The Journal of Molecular Diagnostics : Jmd. 12: 58-64. PMID 19959796 DOI: 10.2353/Jmoldx.2010.090068 |
0.361 |
|
| 2010 |
Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs KD, Merker JD, Zehnder JL, Nolan GP, Gotlib J. Abstract 239: Mutation of the inhibitory adaptor protein LNK drives potentiated JAK-STAT signaling in patients with JAK2 V617F-negative myeloproliferative neoplasms Cancer Research. 70: 239-239. DOI: 10.1158/1538-7445.Am10-239 |
0.359 |
|
| 2010 |
Oh ST, Zahn JM, Simonds EF, Bell J, Natsoulis G, Buenstro J, Jones C, Hale MB, Goltsev Y, Gibbs KD, Merker JD, Zehnder JL, Davis RW, Nolan GP, Ji HP, et al. Abstract B6: Identification of novel mutations in the inhibitory adaptor protein LNK in patients with JAK2 V617F-negative and -positive chronic myeloproliferative neoplasms Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-B6 |
0.346 |
|
| 2009 |
Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, Jones CD, Simen BB, Hanczaruk B, Nguyen KD, Nadeau KC, Egholm M, Miklos DB, Zehnder JL, Fire AZ. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Science Translational Medicine. 1: 12ra23. PMID 20161664 DOI: 10.1126/Scitranslmed.3000540 |
0.35 |
|
| 2009 |
Weinberg OK, Seetharam M, Ren L, Seo K, Ma L, Merker JD, Gotlib J, Zehnder JL, Arber DA. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood. 113: 1906-8. PMID 19131546 DOI: 10.1182/Blood-2008-10-182782 |
0.324 |
|
| 2008 |
Merker JD, Dominska M, Greenwell PW, Rinella E, Bouck DC, Shibata Y, Strahl BD, Mieczkowski P, Petes TD. The histone methylase Set2p and the histone deacetylase Rpd3p repress meiotic recombination at the HIS4 meiotic recombination hotspot in Saccharomyces cerevisiae. Dna Repair. 7: 1298-308. PMID 18515193 DOI: 10.1016/J.Dnarep.2008.04.009 |
0.523 |
|
| 2008 |
Boyd SD, Merker JD, Zehnder JL, Fire AZ. High-Throughput Sequencing for Diagnosis, Prognosis and Monitoring of Lymphoid Malignancies Blood. 112: 3779-3779. DOI: 10.1182/Blood.V112.11.3779.3779 |
0.376 |
|
| 2006 |
Chiu CY, Rouskin S, Koshy A, Urisman A, Fischer K, Yagi S, Schnurr D, Eckburg PB, Tompkins LS, Blackburn BG, Merker JD, Patterson BK, Ganem D, DeRisi JL. Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: e71-6. PMID 16983602 DOI: 10.1086/507896 |
0.3 |
|
| 2003 |
Merker JD, Dominska M, Petes TD. Patterns of heteroduplex formation associated with the initiation of meiotic recombination in the yeast Saccharomyces cerevisiae. Genetics. 165: 47-63. PMID 14504217 |
0.478 |
|
| 2002 |
Petes TD, Merker JD. Context dependence of meiotic recombination hotspots in yeast: the relationship between recombination activity of a reporter construct and base composition. Genetics. 162: 2049-52. PMID 12524370 |
0.508 |
|
| 2000 |
Merker JD, Datta A, Kolodner RD, Petes TD. The yeast HSM3 gene is not involved in DNA mismatch repair in rapidly dividing cells. Genetics. 154: 491-3. PMID 10681182 |
0.489 |
|
| Show low-probability matches. |